Assenagon Asset Management’s Usana Health Sciences USNA Stock Holding History

Assenagon Asset Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$816K	Sell	38,213 -58,809	-61%	-$1.11M	﹤0.01%	1001
2026 Q1	$1.69M	Sell	97,022 -5,444	-5%	-$108K	﹤0.01%	802
2025 Q4	$2.01M	Buy	102,466 +279	+0.3%	+$5.79K	﹤0.01%	825
2025 Q3	$2.82M	Sell	102,187 -2,223	-2%	-$68.4K	﹤0.01%	756
2025 Q2	$3.19M	Hold	104,410	–	–	﹤0.01%	657
2025 Q1	$2.82M	Sell	104,410 -3,854	-4%	-$122K	﹤0.01%	666
2024 Q4	$3.89M	Sell	108,264 -15,744	-13%	-$589K	0.01%	748
2024 Q3	$4.7M	Buy	124,008 +14,756	+14%	+$606K	0.01%	734
2024 Q2	$4.94M	Buy	109,252 +27,053	+33%	+$1.24M	0.01%	638
2024 Q1	$3.99M	Buy	82,199 +30,485	+59%	+$1.49M	0.01%	659
2023 Q4	$2.77M	Sell	51,714 -12,375	-19%	-$626K	0.01%	812
2023 Q3	$3.76M	Sell	64,089 -15,136	-19%	-$946K	0.01%	650
2023 Q2	$4.99M	Buy	79,225 +17,964	+29%	+$1.14M	0.02%	497
2023 Q1	$3.85M	Buy	61,261 +3,871	+7%	+$231K	0.01%	643
2022 Q4	$3.05M	Sell	57,390 -1,587	-3%	-$86K	0.01%	674
2022 Q3	$3.31M	Hold	58,977	–	–	0.01%	578
2022 Q2	$4.27M	Buy	58,977 +28,618	+94%	+$2.13M	0.02%	594
2022 Q1	$2.41M	Buy	30,359 +831	+3%	+$74.9K	0.01%	763
2021 Q4	$2.99M	Hold	29,528	–	–	0.01%	680
2021 Q3	$2.72M	Sell	29,528 -14	-0%	-$1.35K	0.01%	606
2021 Q2	$3.03M	Sell	29,542 -39,198	-57%	-$3.94M	0.01%	589
2021 Q1	$6.71M	Buy	68,740 +41,105	+149%	+$3.74M	0.03%	436
2020 Q4	$2.13M	Buy	27,635 +2,670	+11%	+$207K	0.01%	515
2020 Q3	$1.84M	Buy	+24,965	New	+$2M	0.01%	610
2020 Q2	–	Sell	-12,546	Closed	-$725K	–	1240
2020 Q1	$725K	Buy	+12,546	New	+$873K	0.01%	595
2019 Q3	–	Sell	-9,978	Closed	-$793K	–	1085
2019 Q2	$793K	Buy	+9,978	New	+$791K	0.01%	763
2019 Q1	–	Sell	-24,884	Closed	-$2.93M	–	1123
2018 Q4	$2.93M	Sell	24,884 -9,983	-29%	-$1.15M	0.03%	347
2018 Q3	$4.2M	Buy	+34,867	New	+$4.33M	0.04%	341
2018 Q2	–	Sell	-10,463	Closed	-$899K	–	605
2018 Q1	$899K	Buy	+10,463	New	+$810K	0.01%	416

Other funds holding USNA

PCM

Park Capital Management Madison, Wisconsin $170M AUM 83.62% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

CAL

Capital Advisors Ltd Shaker Heights, Ohio $991M AUM 19.82% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Assenagon Asset Management's USNA Position: Q2 2026 in Review

Assenagon Asset Management reduced its Usana Health Sciences (USNA) stake by 61% in Q2 2026, selling an estimated $1.11M and leaving 38,213 shares worth $816K. The position accounts for ﹤0.01% of the portfolio, ranked #1001.

Assenagon Asset Management first reported a position in USNA in Q1 2018 and has held it in 29 quarters since. The position peaked at $6.71M in Q1 2021. 8 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

Assenagon Asset Management held 38,213 shares of Usana Health Sciences worth $816K as of Q2 2026.
Assenagon Asset Management sold 58,809 Usana Health Sciences shares in Q2 2026, an estimated $1.11M.
Usana Health Sciences made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #1001 holding.
Assenagon Asset Management first reported a position in Usana Health Sciences in Q1 2018 and has held it in 29 quarters since.
Assenagon Asset Management's Usana Health Sciences position peaked at $6.71M in Q1 2021.
8 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.